Paclitaxel-albumin Clinical Trials

5 actively recruiting trials

Also known as: Injectable paclitaxel (albumin bound), albumin paclitaxel

Pipeline

Phase 2: 4Phase 3: 1

Top Sponsors

Tongji Hospital2
The First Affiliated Hospital of Zhengzhou University1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1
Beijing Tongren Hospital1

Indications

Cancer5
Neoadjuvant Chemoimmunotherapy2
Cervical Cancer2
HRD-positive/HER2-negative Advanced Breast Cancer1
Fludzoparib" and Anti-angiogenic1

Other5 trials

Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC

Phase 2

Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer

Phase 2

Neoadjuvant Immunochemotherapy in PD-L1-negative LACC

Phase 2

Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma

Phase 2

Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.